31 – 40 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
- Contribution to journal › Article
-
Mark
Joint protection in haemophilia
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
- Contribution to journal › Article
-
Mark
Delivery of a severe haemophilia foetus - vaginal delivery
- Contribution to journal › Published meeting abstract
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
(2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
- Contribution to journal › Published meeting abstract
-
Mark
European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
- Contribution to journal › Published meeting abstract
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
- Contribution to journal › Scientific review
